Sysmex Sees ADCC Downclassification As Smoothing Path To HPC Indication
This article was originally published in The Gray Sheet
Executive Summary
Sysmex Corporation expects the new Class II designation for automated differential cell counters (ADCCs) used to count and classify abnormal cells in the blood will facilitate the firm's quest to expand labeling for its SE series automated hematology analyzer.